ASE Technology (ASX) Q2 2026 earnings review
Explosive AI Demand Drives Record Profits, But CapEx Devours Cash
ASE Technology delivered a spectacular second quarter, with Net Income surging 180% year-over-year to NT$21.1 billion. The core ATM (Assembly, Testing, and Material) segment is operating at full throttle, growing revenue by 36% and pushing operating margins higher. However, capturing this AI-driven demand comes at a steep price: the company is spending aggressively to build capacity. CapEx nearly doubled sequentially, pushing Free Cash Flow deep into negative territory and requiring ASE to take on significant new debt. The divergence between the booming ATM business and the margin-compressed EMS business is stark.
🐂 Bull Case
ATM revenue grew an accelerating 36.3% YoY. High utilization and a favorable product mix drove ATM gross margin up 130 basis points sequentially to 27.3%.
Testing revenue remains highly robust, and management's strategic focus is evident in capital allocation, ensuring ASE captures the highly profitable final-test phases of next-gen AI chips.
🐻 Bear Case
Operating cash flow of NT$47.0B was dwarfed by NT$79.8B in property, plant, and equipment payments, resulting in a deeply negative Free Cash Flow.
Despite 11.9% YoY revenue growth, the EMS segment's gross margin compressed to 8.9% (from 9.5% in Q1), dragged down by raw material costs eating up 79% of segment revenue.
⚖️ Verdict: 🟢
Bullish. The aggressive CapEx is a feature, not a bug, of winning the AI supercycle. While the cash burn and EMS weakness are real, the core ATM business is capturing generational growth at expanding margins.
Key Themes
AI & LEAP Fueling ATM Dominance
The Leading-Edge Advanced Packaging (LEAP) supercycle is accelerating. ATM segment revenue jumped 36.3% YoY to NT$126.1B. This top-line explosion translates powerfully to the bottom line, with ATM operating margin expanding from 14.1% in 26Q1 to 15.7% in 26Q2. The company is actively solidifying its moat around advanced AI accelerator packaging.
Testing CapEx Parity Highlights Strategic Shift
In a massive structural shift, ASE invested US$804 million in Testing CapEx in Q2—nearly matching the US$840 million spent on Packaging. Testing CapEx more than doubled sequentially (up from US$326M in Q1). Management is aggressively chasing the margin-accretive AI wafer sort and final test markets, viewing this as their next primary growth engine.
EMS Margin Compression Contradicts Profit Narrative
While the ATM segment prints money, EMS is showing signs of strain. EMS revenue grew 11.9% YoY, but gross margins decelerated from 9.5% in Q1 to 8.9% in Q2. Operating margin fell from 3.0% to 2.4%. With raw materials accounting for 79% of EMS revenue, the segment has zero pricing power to offset supply chain costs.
Free Cash Flow Reversing and Debt Climbing
ASE is buying its growth. Reversing from a historically cash-generative stance, the company posted a massive negative Free Cash Flow of ~NT$32.8B in Q2 (NT$47.0B operating cash flow minus NT$79.8B PPE payments). To fund this, short-term borrowings jumped NT$10B sequentially, and bonds payable skyrocketed from NT$2.0B to NT$15.0B. Leverage is increasing precisely when global macro conditions are volatile.
Non-Operating Items Pad the Bottom Line
The 180% YoY surge in net income wasn't purely operational. The company booked a massive NT$3.6 billion net gain on foreign exchange hedging activities and another NT$2.3 billion gain on equity-method investments. While operational leverage is real, investors should strip out these NT$5.9 billion in financial gains to gauge true underlying run-rate profitability.
Operational Leverage Offsets Labor Costs
Despite a massive hiring spree (adding over 6,200 employees sequentially to reach 114,179), labor costs remained contained at 11% of total net revenues (down from 12% in Q1). The company is successfully squeezing higher productivity and utilization out of its expanded workforce.
Other KPIs
Accelerating. Up 180% YoY and 49% sequentially. Driven by explosive top-line growth in ATM, 130 bps of ATM gross margin expansion, and a very favorable NT$3.6B forex hedging gain.
Accelerating significantly from NT$38.1B in 26Q1 and NT$27.4B in 25Q2, highlighting the massive cash-generating power of the underlying operations before the heavy toll of depreciation and CapEx are factored in.
Deteriorating. Increased from 0.40 at the end of Q1 2026. This reflects the massive issuance of new bonds (up to NT$15.0B) and borrowings required to fund the US$1.69B quarterly CapEx program.
Key Questions
CapEx Returns and Cash Flow
With Testing CapEx surging to $804M in a single quarter and pushing Free Cash Flow deeply negative, in what quarter do you expect the cash flow profile to inflect back to positive? What is the expected payback period for these new AI-centric testers?
EMS Margin Deterioration
EMS gross margin fell 60 basis points sequentially despite a 6.3% increase in revenue. Is this purely a product mix issue, or are you facing structural material cost inflation that you cannot pass on to customers?
Sustainability of Non-Operating Gains
You recorded a very large NT$3.6 billion gain on foreign exchange hedging this quarter. How much of the 130 basis point sequential improvement in ATM gross margin was aided by underlying currency depreciation versus actual pricing/utilization power?
Capacity Utilization Outside Taiwan
With leading-edge capacity in Taiwan 'very, very full', how much progress has been made in migrating mainstream or automotive wirebond demand to your overseas facilities to improve overall global utilization?